Rivaroxaban in heart failure and conorary artery disease: the COMMANDER-HF study.

28 August 2018 (13:15 - 13:30)
Organised by:
Congress Presentation Part of: New directions in the management of thrombotic risks in patients with heart failure Treatment ESC Premium Access ESC Congress 2018